Roger E Moore

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Transcription Factor

Human Immunodeficiency Virus

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)
Xiaobao Xu, Anthony K C Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrotte, Jun Wu, Rui Su, Markus Müschen, Steven T Rosen, Jianjun Chen, Lu Yang, Chun-Wei David Chen
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Science advances 8 (51) (2022)